/ BSX
Boston Scientific Corporation’s Q4 2024 Net Sales Surge by 22.4%, Exceeding Expectations
Boston Scientific Corporation reported robust financial results in Q4 2024, with net sales reaching $4.561 billion, a 22.4% increase from the previous year.
February 05, 2025BSX Reports $4.12 Billion in Q2 2024 Net Sales, Up 14.5% from Q2 2023
Boston Scientific Corporation (NYSE: BSX) has reported robust financial results for the second quarter of 2024.
July 24, 2024Boston Scientific (BSX) Beats Expectations with $3.8 Billion in Q1 Net Sales
Boston Scientific Corporation (NYSE: BSX) reported a significant growth in net sales for the first quarter of 2024, reaching $3.856 billion.
April 24, 2024Boston Scientific Corporation (BSX) Reports $0.50 Adjusted EPS, $3.73B Revenue for Q3
Boston Scientific reports Q3 results with a strong revenue of $3.73 billion and an adjusted EPS of $0.50.
January 31, 2024